Big Data Analytics for Prostate Radiotherapy
Open Access
- 14 June 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 6, 149
Abstract
Radiation therapy is a first-line treatment option for localized prostate cancer and radiation-induced normal tissue damage are often the main limiting factor for modern radiotherapy regimens. Conversely, under-dosing of target volumes in an attempt to spare adjacent healthy tissues limits the likelihood of achieving local, long-term control. Thus, the ability to generate personalized data-driven risk profiles for radiotherapy outcomes would provide valuable prognostic information to help guide both clinicians and patients alike. Big data applied to radiation oncology promises to deliver better understanding of outcomes by harvesting and integrating heterogeneous data-types, including patient-specific clinical parameters, treatment related dose-volume metrics and biological risk factors. When taken together, such variables make up the basis for a multi-dimensional space (the “RadoncSpace”) in which the presented modelling techniques search in order to identify significant predictors. Herein, we review outcome modelling and big data-mining techniques for both tumor control and radiotherapy-induced normal tissue effects. We apply many of the presented modelling approaches onto a cohort of hypofractionated prostate cancer patients taking into account different data-types and a large heterogeneous mix of physical and biological parameters. Cross-validation techniques are also reviewed for the refinement of the proposed framework architecture and checking individual model performance. We conclude by considering advanced modelling techniques that borrow concepts from big data analytics, such as machine learning and artificial intelligence, before discussing the potential future impact of systems radiobiology approaches.Keywords
This publication has 157 references indexed in Scilit:
- Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Charged particles in radiotherapy: A 5-year update of a systematic reviewRadiotherapy and Oncology, 2012
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms (SNPs) Associated With the Development of Erectile Dysfunction in African-American Men After Radiotherapy for Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Biomarkers and Surrogate Endpoints for Normal-Tissue Effects of Radiation Therapy: The Importance of Dose–Volume EffectsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Improving Normal Tissue Complication Probability Models: The Need to Adopt a “Data-Pooling” CultureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- A systems biology view of cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2009
- A decision aid for intensity-modulated radiation-therapy plan selection in prostate cancer based on a prognostic Bayesian network and a Markov modelArtificial Intelligence in Medicine, 2009
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analysesInternational Journal of Cancer, 2005